Oppenheimer has highlighted several stocks, including Apple (AAPL), Alcoa (AA), Baker Hughes (BKR), and Amgen (AMGN), as top performers for momentum.

Oppenheimer has reduced its price target for Zscaler (ZS) shares from $345 to $280.

Innoviva's CEO outlined a three-part growth strategy, a $125 million share buyback, and key catalysts for 2026 during the Oppenheimer Conference.

Il premio Oscar Cillian Murphy ama i personaggi in crisi. Come Oppenheimer o come Tommy Shelby, che torna a interpretare nel film sui Peaky Blinders. Ma poi si porta a casa le inquietudini dei ruoli?

An Oppenheimer analyst has turned bullish on Oracle’s stock after a selloff that has wiped away more than half the company’s value since its September peak.

Cantor and Oppenheimer have maintained a positive outlook on Aurora (AUR), suggesting continued confidence in the company's performance.

Several financial firms have raised their price targets for individual companies, including Diebold Nixdorf, SharkNinja, The Williams Companies, and FedEx, indicating positive outlooks for these stocks.

"My brain just works in a really twisty, worst-case-scenario way," she tells The Hollywood Reporter, while also keeping the door open for spinoffs.

Oppenheimer reports that CrowdStrike remains a top security vendor, while Palo Alto and SentinelOne are also improving their positions in the market.

Oppenheimer has reduced its price target for Intuit (INTU) shares from $696 to $558.

Oppenheimer and Tigress Financial Partners maintain a positive outlook on Mobileye (MBLY), signaling confidence in the company's performance.

Oppenheimer suggests two specific beaten-down stocks that could potentially stage a comeback in the market.

Oppenheimer has raised its guidance for Itron, Inc. (ITRI) after the company provided a better-than-expected outlook for fiscal year 2026.

Oracle's stock has increased following an upgrade from Oppenheimer.

Oppenheimer's recent channel checks suggest a favorable future for two specific cybersecurity stocks, leading to a positive market outlook for them.

Tell Me Lies is going out with a bang. The Season 3 finale, which showrunner Meaghan Oppenheimer says is the series conclusion, drew more than 3.5M views in just its first day on Disney+ and Hulu. That’s up nearly 70% from the Season 3 premiere’s same-day audience, Disney says. Deadline previously reported exclusively that the […]

Warning: This article contains spoilers for Tell Me Lies.  Meaghan Oppenheimer is telling truths, and you may not want to hear what she has to say.  Indeed, the Tell Me Lies showrunner revealed...

Creator Meaghan Oppenheimer has confirmed that the series 'Tell Me Lies' will conclude with its third season, having reached its 'intentional ending'.

Analysts have upgraded the stock ratings for Robinhood, Roku, and Intellia, citing attractive valuations, new collaborations, and positive clinical trial developments.

Oppenheimer has reduced its price target for Elastic (ESTC) shares from $100 to $85.

Oppenheimer analysts predict that the global drone market, particularly the 'lower-skies' category, will grow to $400 billion within the next decade, offering investment opportunities.

Multiple financial institutions have updated their price targets and ratings for various companies, reflecting new outlooks on their performance and market conditions.

Axsome Therapeutics discussed the strong performance of its drug Auvelity, its strategy for a 600-representative sales force, and an upcoming PDUFA date at the Oppenheimer Conference.

Oppenheimer sees shares of Oracle rallying 27% from here.

Oppenheimer has raised its price target for Amrize Ltd (AMRZ) to $70 and maintained an Outperform rating on the stock.

Excitement is building for Christopher Nolan’s next film, 'The Odyssey,' following his successful 'Oppenheimer,' as new trailers and spots are released.